NCT02817659View on ClinicalTrials.gov

To Determine Tolerability to Glucagon Infusion in Obese Subjects

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

November 1, 2016

Primary Completion Date

January 13, 2017

Study Completion Date

December 31, 2025

Conditions

Obesity

Interventions

DRUG

Glucagon

Glucagon infusion

Trial Locations (1)

32804

Translational Research Institute for Metabolism and Diabetes, Orlando

All Listed Sponsors

lead

AdventHealth Translational Research Institute

OTHER